Forecast & RatingOnly 1 analyst currently covers InMed Pharmaceuticals (INM.US), with a price target of $409.53. The sample is very small, so treat this as a reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Feb 29, 2024Price forecast
$409.5330925.35%
Forecast & Rating-
0analysts
Target price forecast
Forecast dateOct 10, 2022
Forecast met0.0%
Stock price$106.20
Avg. target$409.5
High target$410
Low target$410
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.